Erste Asset Management’s Instil Bio TIL Stock Holding History

Erste Asset Management’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,375	Closed	-$15.3K	–	582
2023 Q2	$15.3K	Hold	1,375	–	–	﹤0.01%	558
2023 Q1	$18.2K	Hold	1,375	–	–	﹤0.01%	571
2022 Q4	$18.5K	Hold	1,375	–	–	﹤0.01%	556
2022 Q3	$139K	Hold	1,375	–	–	﹤0.01%	513
2022 Q2	$127K	Hold	1,375	–	–	﹤0.01%	534
2022 Q1	$321K	Buy	+1,375	New	+$321K	0.01%	475

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Erste Asset Management's TIL Position: Q3 2023 in Review

Erste Asset Management sold out of Instil Bio (TIL) in Q3 2023, closing a stake of 1,375 shares — an estimated $15.3K sold.

Erste Asset Management first reported a position in TIL in Q1 2022 and held it in 6 quarters. The position peaked at $321K in Q1 2022. 58 funds tracked by Wall St. Rank hold TIL as of Q3 2023.

Erste Asset Management reported no remaining Instil Bio position as of Q3 2023 after selling out during the quarter.
Erste Asset Management sold 1,375 Instil Bio shares in Q3 2023, an estimated $15.3K.
Erste Asset Management first reported a position in Instil Bio in Q1 2022 and held it in 6 quarters.
Erste Asset Management's Instil Bio position peaked at $321K in Q1 2022.
58 funds tracked by Wall St. Rank held Instil Bio as of Q3 2023.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.